Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Accelerator Corp

VieVax Corp. is focused on commercializing a novel approach to vaccine development that is designed to overcome the limitations of existing vaccine technologies. These technologies, largely unchanged and unimproved for the past half-century, have consistently fallen short in addressing a number of critical issues, including: the spread of serious emerging infectious diseases, the emergence of treatment-resistant strains of infectious pathogens, robust and reliable manufacturing, the growing threat of bioterrorism employing infectious pathogens, and, a failure to evelop vaccines against infectious agents such as HIV.


Contact Details:
1616 Eastlake Ave. E.
Seattle
Washington
98102
United States of America
Tel:206.957.7300
Fax:206.957.7399
Email:info@acceleratorcorp.com
WWW:

www.acceleratorcorp.com/




Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 411 times since April 2007, the link to the organisation's website has been followed 97 times

Recent Search Terms used to find this page: accelerator co | .

Search for more companies in Seattle

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Accelerator Corp

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.